This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Tungsten-Induced Denaturation and Aggregation of Epoetin Alfa During Primary Packaging as a Cause of Immunogenicity
Pharmaceutical Research Open Access 18 November 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sharma, B., Bader, F., Templeman, T., Lisi, P., Ryan, M. & Heavner, G.A. Eur. J. Hospital Pharm 5, 86–91 (2004).
Boven, K., Knight, J., Bader, F., Rossert, J., Eckardt, K.U. & Casadevall, N. Nephrol. Dial. Transplant. 20 Suppl 3, iii33–iii40 (2005).
Boven, K. et al. Kidney Int. 67, 2346–2353 (2005).
Villalobos, A.P., Gunturi, S.R. & Heavner, G.A. Pharm. Res. 22, 1186–1194 (2005).
Schellekens, H. Nat. Rev. Drug Discov. 1, 457–462 (2002).
Casadevall, N., Dupuy, E., Molho-Sabatier, P., Tobelem, G., Varet, B. & Mayeux, P. N. Engl. J. Med. 334, 630–633 (1996).
Ottesen, J.L. et al. Diabetologia 37, 1178–1185 (1994).
Stewart, T.A., Hollingshead, P.G., Pitts, S.L., Chang, R., Martin, L.E. & Oakley, H. Mol. Biol. Med. 6, 275–281 (1989).
http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019520.pdf
Bennett, C.L. et al. N. Engl. J. Med. 351, 1403–1408 (2004).
Kerwin, B. Eur. J. Hosp. Pharm. 2, 42–45 (2005).
Hermeling, S., Schellekens, H., Crommelin, D.J. & Jiskoot, W. Pharm. Res. 20, 1903–1907 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schellekens, H., Jiskoot, W. Eprex-associated pure red cell aplasia and leachates. Nat Biotechnol 24, 613–614 (2006). https://doi.org/10.1038/nbt0606-613
Issue Date:
DOI: https://doi.org/10.1038/nbt0606-613
This article is cited by
-
Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience
PharmacoEconomics (2016)
-
Biosimilar Versus Patented Erythropoietins: Learning from 5 Years of European and Japanese Experience
Applied Health Economics and Health Policy (2015)
-
How Bio-questionable are the Different Recombinant Human Erythropoietin Copy Products in Thailand?
Pharmaceutical Research (2014)
-
EU’s New Pharmacovigilance Legislation: Considerations for Biosimilars
Drug Safety (2014)
-
Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis
Applied Health Economics and Health Policy (2014)